2025 Annual Meeting | C51 - Drugs and Toxin-induced Neurological Emergencies/CNS Toxicities
Program Materials Program Evaluations
| 07:00 AM - 07:35 AM PDT | Speaker |
Drugs of Misuse and the Nervous System
Derek W. Stitt, MD |
| 07:35 AM - 08:10 AM PDT | Speaker |
Neurotoxicity of Oncologic Therapies
Michael W. Ruff, MD |
| 08:10 AM - 08:45 AM PDT | Speaker |
Pharmaceutical Neurotoxicity
Neeraj Kumar, MD |
| 08:45 AM - 09:00 AM PDT | Q&A |
Questions and Answers
Derek W. Stitt, MD |
| Derek W. Stitt, MD | Dr. Stitt has nothing to disclose. |
| Neeraj Kumar, MD | Dr. Kumar has nothing to disclose. |
| Michael W. Ruff, MD | Dr. Ruff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Radmetrix. Dr. Ruff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Ruff has received intellectual property interests from a discovery or technology relating to health care. |